{"result": {"id": "7fe8fb3d-9d3b-49e5-982a-f7bec74e64d1", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>二氢吡啶类 CCB<|>ORGANIZATION<|>二氢吡啶类 CCB是一种降压药，常用于治疗高血压，尤其适用于老年高血压、单纯收缩期高血压等患者，可显著降低心血管风险，特别是脑卒中风险\")\n##\n(\"entity\"<|>非二氢吡啶类 CCB<|>ORGANIZATION<|>非二氢吡啶类 CCB适用于高血压合并冠心病心绞痛、心率增快、室上性快速心律失常等患者，具有负性变时和负性肌力作用\")\n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>ACEI是一种降压药，通过抑制血管紧张素转换酶发挥降压作用，适用于伴LVH、慢性心力衰竭、慢性冠心病等患者\")\n##\n(\"entity\"<|>CYP3A4<|>ORGANIZATION<|>CYP3A4是细胞色素P450 3A4，参与维拉帕米和地尔硫的代谢\")\n##\n(\"relationship\"<|>二氢吡啶类 CCB<|>非二氢吡啶类 CCB<|>二氢吡啶类 CCB和非二氢吡啶类 CCB可以合用治疗难治性高血压<|>6)\n##\n(\"relationship\"<|>非二氢吡啶类 CCB<|>CYP3A4<|>非二氢吡啶类 CCB中的维拉帕米和地尔硫由CYP3A4代谢<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558614, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 336, "prompt_tokens": 2499, "total_tokens": 2835, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 707}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ��血压控制和 BPV[242-243] 。\n　　我国既往完成的较大样本的降压治疗临床试验多 以二氢吡啶类 CCB为研究用药 ,并证实以二氢吡啶类 CCB为基础的降压治疗方案可显著降低高血压患者 的心血管风险 ,特别是脑卒中风险[218,220,222] 。\n　　　长效二氢吡啶类 CCB可与其他常用降压药联合 应用 ,尤 其 适 用 于 老 年 高 血 压、单 纯 收 缩 期 高 血 压 (isolated systolic hypertension, ISH) 、伴稳定性心绞 痛、冠 状 动 脉 或 颈 动 脉 粥 样 硬 化 及 周 围 血 管 病 患 者[244-246] 。常见不良反应包括反射性交感神经激活导 致心跳加快、面部潮红、脚踝部水肿、牙龈增生等 。短 效硝苯地平的不良反应明显 ,并且易引起血压波动 ,不 推荐作为常用降压药使用 ,不宜用于急性冠脉综合征 患者[247] 。二氢吡啶类 CCB没有绝对禁忌证 ,但心动 过速与心力衰竭患者慎用。\n　　非二氢吡啶类 CCB的随机对照试验较少 ,改善心  血管预后方面与其他降压药比较无实质性差异[133] 。 非二氢吡啶类 CCB适用于高血压合并冠心病心绞痛、 心率增快、室上性快速心律失常、CKD 以及原发性醛  固酮增多症筛查 ,可与二氢吡啶类 CCB合用治疗难治  性高血 压[248] 。 非 二 氢 吡 啶 类 CCB 比 二 氢 吡 啶 类  CCB更具负性变时和负性肌力作用 ,可发生二度至三  度房室传导阻滞 ,心力衰竭和高度房室传导阻滞患者  禁忌使用 。维拉帕米和地尔硫均由细胞色素 P450 3A4(cytochromeP4503A4,CYP3A4)代谢 ,与二氢吡  啶类 CCB相比具有更多的药物-药物相互作用[248] 。\n　　　(2) ACEI: ACEI的作用机制是抑制血管紧张素  转换酶(angiotensin-converting enzyme, ACE) , 阻断  血管紧张素 Ⅱ(angiotensin Ⅱ ,AngⅡ) 的生成 ,抑制激  肽酶的降解而发挥降压作用 。ACEI还能促进 ACE2 的活性 , 阻 断 血 管 紧 张 素 (1-7) [angiotensin(1-7) ,  Ang(1-7)] 的降解 ,进一步起到扩张血管及抗增生的  作用[249] 。以往大量的大规模临床随机对照试验结果  显示 ,此类药物对于高血压患者具有良好的靶器官保  护和预防心血管终点事件的作用[250]  ,是适应证最为  广泛的降压药 。ACEI尤其适用于伴 LVH、慢性心力  衰竭、慢性冠心病、心肌梗死后心功能不全、CKD、蛋  白尿患者[249-251] 。利�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_e76088c9b437f809ddfac6c22cc5e6bef830e95ae741c1bcead057813e6b2467_v2"}